(RTTNews) - Aurora Cannabis Inc. (ACB.TO), a medical cannabis company based in Canada, Thursday has announced the discovery of a novel genetic resistance source against powdery mildew, known as PM2.

ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides ...

Aurora shares are trading higher on Thursday after the company announced it discovered a novel source of genetic resistance against powdery mildew.

Aurora Cannabis shares jumped Thursday morning after the cannabis company said it has discovered a genetic resistance that protects its plants from crop disease. Shares rose 12% to 6.98 Canadian ...

Aurora Cannabis (ACB) is pleased to announce the company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that ...

Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science. EDMONTON, AB , March 20, ...

EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's ...

EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of ...